Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

teglarinad chloride

A water-soluble prodrug of a cyanoguanidine compound with potential antineoplastic activity. In vivo, teglarinad chloride is rapidly converted into active drug through hydrolytic cleavage of a carbonate ester bond. Although the exact mechanism of action has yet to be fully elucidated, the active drug appears to antagonize nuclear factor-kappa B (NF-kB) transcription, resulting in the induction of tumor cell apoptosis.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:apoptosis inducer GMX1777
Code name:GMX1777
Chemical structure:4-({N-[6-(4-chlorophenoxy)hexyl]-N'-cyanocarbamimidoyl}amino)-1-(3-oxo- 2,4,7,10,13,16-hexaoxaheptadecan-1-yl)pyridinium chloride
pyridinium, 4-[[[[6-(4-chlorophenoxy)hexyl]amino](cyanoamino) methylene]amino]-1-(3-oxo-2,4,7,10,13,16-hexaoxaheptadec-1-yl)-, chloride
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search